Home > Analytics > EVEXIA LIFECARE

EVEXIA LIFECARE
Intrinsic Value | Fundamental Analysis

BOM : 524444     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
May 28,2024
Price(EOD): ₹ 2.48
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 193.29 Cr
Value of ₹ 1 Lac invested in EVEXIA LIFECARE
on May 28,2019 (price: ₹ 4.93)

₹ 1 L

₹ 0.50 L

1W : 1.6% 1M : -0.8% 1Y : -10.1%
COMMUNITY POLL
for EVEXIA LIFECARE
Please provide your vote to see the results
EVEXIA LIFECARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
EVEXIA LIFECARE 1.6% -0.8% -10.1%
ADANI ENTERPRISES 3.3% 5.3% 32.8%
REDINGTON -3.6% -8.6% 21.5%
HONASA CONSUMER -1.3% -1.9% NA
MMTC -4.9% -5.6% 147%
MSTC -9.3% 0.1% 213.1%
LLOYDS ENTERPRISES -3% -13.6% 295.3%
VERITAS (INDIA) -0.4% -9.1% 712.5%
NOVARTIS INDIA -4.9% -1% 51.7%

FUNDAMENTAL ANALYSIS OF EVEXIA LIFECARE

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF EVEXIA LIFECARE

 
Valuation Score
[As on : May 28,2024 ]

Ratio Consolidated
P/E
P/B
P/S
153.16
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 1.26 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

2.14
P/B Calculated based on Book Value of Rs 90.49 Cr
[Latest Year - Mar2023 - Consolidated Results ]

3.43
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 56.29 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF EVEXIA LIFECARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
NA (-ve EV)
77%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF EVEXIA LIFECARE



EVEXIA LIFECARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF EVEXIA LIFECARE

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
8.29
0.08
0.09
2.82
8.5
0.08
0.09
2.89
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF EVEXIA LIFECARE

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF EVEXIA LIFECARE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
258.05%
3450%
16290%
18073.3%
-0.24%
2250%
664.2%
430.42%
QtrlyTrend
6
Latest Qtr: Mar2024
Quarterly Result Analysis →

Insights 💡 EVEXIA LIFECARE is one of the top 47% companies with good quarterly result uptrend ! Discover More →

EVEXIA LIFECARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about EVEXIA LIFECARE


Is EVEXIA LIFECARE good for long term investment?

As on May 28,2024, the Fundamentals of EVEXIA LIFECARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of EVEXIA LIFECARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is EVEXIA LIFECARE UnderValued or OverValued?

As on May 28,2024, EVEXIA LIFECARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of EVEXIA LIFECARE ?

As on May 28,2024, the Intrinsic Value of EVEXIA LIFECARE is Rs. 1.40 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -6.61
Fair Value [Median EV / Sales Model] : Rs. -5.08
Fair Value [Median Price / Sales Model] : Rs. 1.40
Estimated Median Fair Value of EVEXIA LIFECARE : Rs. 1.40

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is EVEXIA LIFECARE trading at a Premium or Discount?

As on May 28,2024, EVEXIA LIFECARE is trading at a Premium of 78% based on the estimates of Median Intrinsic Value!